Comprehensive molecular and clinical findings in 29 patients with multi-locus imprinting disturbance

• Published in: Clinical epigenetics Vol. 16; no. 1; pp. 138 - 18
• Main Authors: Urakawa, Tatsuki, Soejima, Hidenobu, Yamoto, Kaori, Hara-Isono, Kaori, Nakamura, Akie, Kawashima, Sayaka, Narusawa, Hiromune, Kosaki, Rika, Nishimura, Yutaka, Yamazawa, Kazuki, Hattori, Tetsuo, Muramatsu, Yukako, Inoue, Takanobu, Matsubara, Keiko, Fukami, Maki, Saitoh, Shinji, Ogata, Tsutomu, Kagami, Masayo
• Format: Journal Article
• Language: English
• Published: Germany BioMed Central Ltd 05.10.2024; BioMed Central; BMC
• Subjects: Array-based methylation analysis; Beckwith-Wiedemann Syndrome - genetics; Child; Child, Preschool; DNA Methylation - genetics; Epigenesis, Genetic - genetics; Female; Genomic Imprinting - genetics; Humans; Imprinting disorders; Male; Medical research; Medicine, Experimental; Methylation; MS-MLPA; Multi-locus imprinting disturbance; Phenotype; Prader-Willi syndrome; Proteins; Pyrosequencing; Silver-Russell Syndrome - genetics; Subcortical maternal complex; Netherlands; Imprinting disorders; Multi-locus imprinting disturbance; Whole-exome sequencing; MS-MLPA; Pyrosequencing; Subcortical maternal complex; Array-based methylation analysis
• ISSN: 1868-7083; 1868-7075; 1868-7083
• DOI: 10.1186/s13148-024-01744-5

Multi-locus imprinting disturbance (MLID) with methylation defects in various differentially methylated regions (DMRs) has recently been identified in approximately 150 cases with imprinting disorders (IDs), and deleterious variants have been found in genes related to methylation maintenance of DMRs, such as those encoding proteins constructing the subcortical maternal complex (SCMC), in a small fraction of patients and/or their mothers. However, integrated methylation analysis for DMRs and sequence analysis for MLID-causative genes in MLID cases and their mothers have been performed only in a single study focusing on Beckwith-Wiedemann syndrome (BWS) and Silver-Russell syndrome (SRS) phenotypes. Of 783 patients with various IDs we have identified to date, we examined a total of 386 patients with confirmed epimutation and 71 patients with epimutation or uniparental disomy. Consequently, we identified MLID in 29 patients with epimutation confirmed by methylation analysis for multiple ID-associated DMRs using pyrosequencing and/or methylation-specific multiple ligation-dependent probe amplification. MLID was detected in approximately 12% of patients with BWS phenotype and approximately 5% of patients with SRS phenotype, but not in patients with Kagami-Ogata syndrome, Prader-Willi syndrome, or Angelman syndrome phenotypes. We next conducted array-based methylation analysis for 78 DMRs and whole-exome sequencing in the 29 patients, revealing hypomethylation-dominant aberrant methylation patterns in various DMRs of all the patients, eight probably deleterious variants in genes for SCMC in the mothers of patients, and one homozygous deleterious variant in ZNF445 in one patient. These variants did not show gene-specific methylation disturbance patterns. Clinically, neurodevelopmental delay and/or intellectual developmental disorder (ND/IDD) was observed in about half of the MLID patients, with no association with the identified methylation disturbance patterns and genetic variants. Notably, seven patients with BWS phenotype were conceived by assisted reproductive technology (ART). The frequency of MLID was 7.5% (29/386) in IDs caused by confirmed epimutation. Furthermore, we revealed diverse patterns of hypomethylation-dominant methylation defects, nine deleterious variants, ND/IDD complications in about half of the MLID patients, and a high frequency of MLID in ART-conceived patients.